Rocky Mountain spotted fever (RMSF) is a tick-borne infection caused by Rickettsia rickettsii. We report a cluster of fatal cases of RMSF in 2007 in Panama, involving a pregnant woman and two children from the same family. The woman presented with a fever followed by respiratory distress, maculopapular rash, and an eschar at the site from which a tick had been removed. She died four days after disease onset. This is the second published report of an eschar in a patient confirmed by PCR to be infected with R. rickettsii. One month later, the children presented within days of one another with fever and rash and died three and four days after disease onset. The diagnosis was confirmed by immunohistochemistry, PCR and sequencing of the genes of R. rickettsii in tissues obtained at autopsy.
Introduction
Rocky Mountain spotted fever (RMSF) is a systemic tick-borne infection caused by Rickettsia rickettsii, a Gram-negative, obligate intracellular bacterium with two immunodominant cell surface proteins, protein A (OmpA) and protein B (OmpB). Serologic diagnosis is based on the identification of serum antibodies reactive to these proteins [1] . However, serology is neither sensitive nor informative during the acute phase of the illness [2] , and diagnostic reagents are not widely available in Panama. Furthermore, due to cross-reactivity among Rickettsia species, serology is non-specific. Molecular diagnosis by amplification and sequencing of several rickettsial genes such as ompA, ompB and the citrate synthase (gltA) genes, enable speciesspecific identification of rickettsiae [3, 4] . Unfortunately, PCR testing is performed only in specialized laboratories and is only moderately sensitive, primarily due to a very small number of rickettsiae present in human blood, even during the most severe stage of infection [5] .
The early diagnosis of RMSF therefore depends heavily on clinical suspicion. Patients with fever, headache, malaise, myalgias, and rash, however, can have a variety of infections and excluding these can result in significant diagnostic delays. Untreated, RMSF has a case fatality as high as 30% [6] and timely treatment with doxycycline decreases mortality and morbidity. Tetracyclines are the drugs of choice, but during pregnancy chloramphenicol may be considered [7] .
In Panama, the first cases of RMSF were reported by Rodaniche in 1950 [8] and in 1953, the tick Amblyomma cajennense was identified as the main vector of R. rickettsii in the region [9] .
Subsequently there were no case reports until 2004, when a child was diagnosed with the disease [10] . In this manuscript we report a family cluster of three fatal cases that included a pregnant woman and two children in 2007. Case 1 In October 2007, a pregnant 22-year old female at 23 weeks' gestation presented to a medical center in Panama City, with a one-day history of fever, headache, myalgias, retro-orbital pain, and cough. She was prescribed amoxicillin and sent home. At the time of her visit to the center, a tick was removed from the internal face of her upper left leg. Two days later (three days after onset of symptoms), she was admitted to the intensive care unit in respiratory distress. An eschar ( Figure 1A ) was noted at the site of tick removal and she had a generalized maculopapular rash over her chest and extremities ( Figure 1B Molecular tests were performed for influenza, dengue and Borrelia. All serologic and molecular tests were negative. Bacterial blood cultures were also negative. The patient died one day after hospitalization, four days after disease onset. Autopsy findings included myocarditis, pulmonary edema, centrilobular renal necrosis, active splenic vasculitis, hepatomegaly with centrilobular hepatic ischemia and necrosis, moderate cerebral edema, and a normal fetus of adequate weight for gestational age. Formalin-fixed, paraffin-embedded spleen tissue, obtained from the mother at autopsy, was sent to ICGES and subsequently to the United States Centers for Disease Control and Prevention (CDC) for confirmatory testing. No tissue samples were taken from the fetus.
Case reports

Case 2
At the end of November 2007, the niece of Case 1, a 5-year-old girl, presented with fever, nausea, and abdominal pain of three days duration. She was treated with diclofenac but due to worsening abdominal pain was taken to a pediatric hospital with suspected bacteremia. Physical examination revealed an awake, alert, but tearful girl with mild dehydration and abdominal tenderness in the right lower quadrant. She was treated with ampicillin and intravenous fluids. Several hours later, she developed petechiae on the chest, extremities and palate. Four hours later, she became disoriented with generalized petechiae, cyanosis and weakened pulse. Laboratory examination showed thrombocytopenia (15.0 x 10 3 platelets/mm 3 ), and leukocytosis (10.4 x 10 3 cells/mm 3 ) with 49% blasts and toxic granulations in the neutrophils. The patient developed a generalized tonic-clonic seizure and died, four days after disease onset. Fresh, unfixed liver and spleen samples were sent to ICGES for diagnostic evaluation.
Case 3
The three-year-old sister of Case 2 presented at the end of November with a two-day history of fever, rash and one episode of syncope. She was taken to the emergency room and pronounced dead on arrival. She died the same day as her sister, three days after disease onset. Fresh, unfixed liver and spleen samples were also sent to ICGES.
Diagnostic studies
All three cases were diagnosed as RMSF based on PCR amplification of a 401bp gltA fragment of Rickettsia from the liver and spleen samples of each patient using primers CS-78F and CS-323R and sequencing [11] . The gltA sequences obtained from each patient by ICGES were identical to each other (NCBI accession numbers JF739385 -JF739387) and had 100% sequence identity to the homologous fragment of the gltA from R. rickettsii. A 532-bp ompA fragment was also amplified from spleen and liver samples from the adult female patient using primers Rr190.70 and Rr190.602 [12] at the CDC. The restriction fragment profile of the ompA fragments obtained using enzymes PstI and RsaI was identical to that of R. rickettsii ( Figure 1C ) and the nucleotide sequences of the amplicons were identical to the homologous fragment of R. rickettsii (NCBI accession number JF912515). Abundant spotted fever group rickettsial antigens were identified in the spleen of the Case 1 patient ( Figure 1D ) by using an immunohistochemical staining technique at CDC [2] . Serologic evaluation for the presence of IgG and IgM class antibodies against R. rickettsii using indirect immunofluorescent assays (IFA; Focus Technologies, Cypress, USA) was negative for the adult female patient at four days after disease onset. Serologic tests (EIA) for Leptospira, hantavirus, and dengue were also negative. Blood cultures of the children were negative for Neisseria meningitidis.
Discussion
In 2007, the Gorgas Memorial Institute of Health Studies (ICGES) and the CDC used molecular tools to confirm RMSF as the cause of death in three Panamanian patients. The fatal outcome of these cases was related to rapid disease progression, lack of appropriate antibiotic therapy, and the infrequency with which rickettsioses present in Panama.
In Case 1, diagnosis was further complicated because more common conditions associated with pregnancy, such as HELPP syndrome, can have a similar presentation to RMSF [7] .
One interesting aspect of this report is the family clustering. Case 1 was the aunt-in-law of the two young sisters and all lived in the same house, which had many openings to the external environment, domestic dogs, and a semi-rural setting. Attempts to collect ectoparasites from the dogs and house after the patients' deaths were unsuccessful as an intensive pest-eradication regime using insecticide had been used by the family. Although the parents of the two children could not recall tick bites on their daughters, there was 100% identity among the gltA sequences of R. rickettsia detected in the tissue samples from the three patients, and the deaths occurred within a month of each other. Family clusters of RMSF cases have been previously reported in many other countries, and result when patients share environmental exposures [6] .
Another important aspect of this report is the presence of an eschar in Case 1. Eschars appear to be more common in less severe rickettsioses, such as Rickettsia parkeri rickettsiosis [13] [14] [15] ; rickettsialpox, caused by Rickettsia akari; 364D rickettsiosis, [15] ; and Rickettsia massiliae rickettsiosis [16] [17] . By contrast, the occurrence of an eschar on a patient with RMSF is described rarely: the first and second cases, both fatal and diagnosed by IFA, occurred in North Carolina and Tennessee in 1981 [18] ; and the third case, which represents the first molecular confirmation of an eschar-associated rickettsioses caused by R. rickettsii, was reported in North Carolina in 2011 [19] .
The first cases of RMSF in Panama were reported in 1950 [8] , and after more than 50 years of no known occurrence of RMSF, six [20] [21] [22] [23] . None of the recent Panamanian cases had travelled outside Panama, suggesting that R. rickettsii and its vectors are still present in the country. In Panama, the diagnosis of RMSF is performed only in specialized laboratories, contributing to under-diagnosis and reporting of the disease.
The six documented cases of RMSF in the last decade in Panama have had a case fatality rate of 100%. Given the scarcity of reports of RMSF in the region, there is a low level of awareness of the disease amongst physicians. Also, the similar presenting signs of RMSF to far more common endemic infections, such as dengue, leads to low clinical suspicion of the disease. The detection of an increasing number of fatal cases of RMSF suggests that clinicians should ask about tick bites in patients presenting with febrile illnesses in Panama and in other countries of Central America and consider early empiric therapy with doxycycline or chloramphenicol as appropriate. In suspected RMSF cases with compatible clinical manifestation, tick bite is not always evident or recollected and should not dissuade physicians from doxycycline therapy.
Also, treatment should not be delayed until laboratory test results are available.
Increased awareness of RMSF and referral of suspected cases for testing is necessary to improve surveillance of the disease in Panama, particularly as glucose-6-phosphate dehydrogenase deficiency, a genetic condition which accelerates the progression of fulminant RMSF [24] , is commonly reported in Panama [25] . It is also extremely important to promote public awareness about the potential health consequences of tick bites, as one of the most effective measures against RMSF is close inspection of the head, body and clothes after exposure to wooded and rural areas and careful removal of any attached ticks with tweezers [2] .
Disclaimer
